Linglong Tang

31PUBLICATIONS

102CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMicro- and nanosystemsMedical infection agents (incl. prions)Radiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (31)

Sort by Publication Date:

|Jul 01, 2026

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Jun 10, 2026

TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|Apr 15, 2026

Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy.

|Mar 12, 2026

Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang

|Mar 10, 2026

TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy.

Zhimin Xu, Zhe Li, Zhenji Deng

|Mar 06, 2026

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.

Sai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao

Pageof 6

Frequent Collaborators

26 joint publications

Jun Ma

18 joint publications

Ying Sun

Na Liu

Xu Liu

Wen-Fei Li

Yan-Ping Mao

Yu-Pei Chen

Ji-Bin Li

Yin Zhao

Cheng Xu

Frequent Collaborators

26 joint publications

Jun Ma

18 joint publications

Ying Sun

8 joint publications

Na Liu

7 joint publications

Xu Liu